Enrolling by invitation
JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study
NCT06882876
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Xiangya Hospital Changsha, Hunan, China